Active ingredients at their site of action

Personalized implants that release drugs exactly where they are supposed to act

Logo: Bacta Implants Your personlized therapy

Round window niche implant (RNI) for the treatment of hearing loss

To date, no medications are approved for the treatment of the various forms of hearing loss. One reason for this is that drugs have to be applied locally to the inner ear to have a beneficial effect. But until today, there is no approved device bringing the drug into the inner ear.
Bacta Implants technology enables the production of implants, fitting precisely and safe to your individual round window niche, which connects your middle and inner ear and allows inner ear therapy with minimal invasion.Our first product will be the Round Window Niche Implant (RNI), which delivers the drug dexamethasone, approved for decades, into the inner ear to treat sudden sensorineural hearing loss (ISSHL) – colloquially known as hearing loss.

Circle with text: Currently, our round window implants are in clinical trials. We plan to have the implants avaible for clinical use by 2028

Further information


You want to treat sudden idiopathic sensorineural hearing loss, but all conventional methods failed?


You suffer from idiopathic sudden sensorineural hearing loss?


You aim to administer an active substance into a living being, but the systemic application is not effective enough?

We are founding a start-up company from the Hannover Medical School and open for investors.

Nach oben scrollen
Cookie Consent with Real Cookie Banner